Abstract PR002: Surveillance-detected pancreatic cancers: Updated report from the PRECEDE Consortium
The Pancreatic Cancer Early Detection (PRECEDE) Consortium is a multinational prospective longitudinal cohort study of participants with elevated heritable risk for pancreatic adenocarcinoma (PC). PRECEDE aims to support surveillance for high-risk individuals (HRIs) to inform clinical practice and public health p...